BridgeBio Oncology Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
BridgeBio Oncology Therapeutics, Inc. has filed 170 SEC EDGAR filings since 20 Dec 2023

SEC filing history

Showing 76-100 of 170 matching filings.

Per page
25
Current page
4
3

3

Filing date
18 Aug 2025
Reporting date
11 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
18 Aug 2025
Reporting date
11 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
18 Aug 2025
Reporting date
11 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
18 Aug 2025
Reporting date
11 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
18 Aug 2025
Reporting date
11 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
18 Aug 2025
Reporting date
11 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
18 Aug 2025
Reporting date
11 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
18 Aug 2025
Reporting date
11 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
18 Aug 2025
Reporting date
11 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-288222

POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-4

Filing date
15 Aug 2025
Reporting date
Not listed
Next action
Verify source filing
SCHEDULE 13D/A File 005-94447

SCHEDULE 13D/A filing

Filing date
13 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Aug 2025
Reporting date
11 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41955

CURRENT REPORT

Filing date
13 Aug 2025
Reporting date
11 Aug 2025
Next action
Verify source filing
3

3 filing

Filing date
11 Aug 2025
Reporting date
11 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Aug 2025
Reporting date
11 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Aug 2025
Reporting date
11 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Aug 2025
Reporting date
11 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Aug 2025
Reporting date
11 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Aug 2025
Reporting date
11 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41955

CURRENT REPORT

Filing date
06 Aug 2025
Reporting date
06 Aug 2025
Next action
Verify source filing
425 File 001-41955

CURRENT REPORT

Filing date
04 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41955

CURRENT REPORT

Filing date
04 Aug 2025
Reporting date
04 Aug 2025
Next action
Verify source filing
10-Q File 001-41955

QUARTERLY REPORT

Filing date
01 Aug 2025
Reporting date
30 Jun 2025
Next action
Verify source filing
SCHEDULE 13G/A File 005-94447

SCHEDULE 13G/A filing

Filing date
30 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-94447

SCHEDULE 13G filing

Filing date
24 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .